Suchergebnisse - (Subject:"Siltuximab")

PubPharm (14)

1

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2020

von Fajgenbaum, D. | Wu, D. | Goodman, A. | +21

2

Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease : a prespecified, open-label, extension analysis of two trials

enthalten in: The Lancet. Haematology | 2020

von van Rhee, F. | Casper, C. | Voorhees, P. | +4

3

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma : an open-label phase I trial

enthalten in: Blood cancer journal | 2016

von Shah, J. | Feng, L. | Thomas, S. | +8

4

Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma

enthalten in: International journal of hematology | 2015

von Suzuki, K. | Ogura, M. | Abe, Y. | +9

5

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects

enthalten in: Clinical pharmacology in drug development | 2014

von Xu, C. | Han, C. | Marini, J. | +9

6

A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Angevin, E. | Tabernero, J. | Elez, E. | +19

7

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Thomas, S. | Suvorov, A. | Noens, L. | +10

8

A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Kurzrock, R. | Voorhees, P. | Casper, C. | +14

9

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

enthalten in: Investigational new drugs | 2013

von Hudes, G. | Tagawa, S. | Whang, Y. | +6

10

Paraneoplastic thrombocytosis in ovarian cancer

enthalten in: The New England journal of medicine | 2012

von Stone, R. | Nick, A. | McNeish, I. | +31

ErratumIn: N Engl J Med. 2012 Nov;367(18):1768 Lamkin, Donald [added]